Prof. Claudio Peruccio
European & RCVS Specialist in Veterinary Ophthalmology
DVM, Specialist Small Animal Diseases (SCMPA). Associate Professor at the Faculty of Veterinary Medicine, University of Torino, Italy until 2006.
Diplomate European College of Veterinary Ophthalmologists (ECVO) and founding member since 1993.
Honorary Diplomate of the American College of Veterinary Ophthalmologists (ACVO). Member and Specialist of the Royal College of Veterinary Surgeons (MRCVS).
From 1974 his main interests are veterinary and comparative ophthalmology.
He studied at the Veterinary Colleges in Illinois, Pennsylvania, Florida and held the office of Adjunct Associate Professor at the Department of Clinical Medicine, College of Vet. Med., University of Illinois, Usa.
In 1997 he has been awarded the World Small Animal Veterinary Association (WSAVA) / WALTHAM International Award for Service to the Profession.
October 10, 2014: He has been nominated Honorary Diplomate of the American College of Veterinary Ophthalmologists (ACVO).
Speaker and lecturer in many meetings in Italy and other Countries, author of many scientific publications, chapters and textbooks.
Founder editor of international and national journals and newsletters: Progress in Veterinary and Comparative Ophthalmology, Progress in Veterinary Neurology, Veterinaria, Ippologia, Orizzonti Veterinary, Hereditary Eye Disease, The Globe.
Founder member and member of the board of the following international and national organizations:
- European College of Veterinary Ophthalmologists (ECVO, President 2014-2016)
- International Society of Veterinary Ophthalmology (ISVO, President 1991-93)
- Italian Small Animal Veterinary Association (AIVPA, President 1982-84)
- Italian Companion Animal Veterinary Society (SCIVAC, Vice-president 1985-87)
- Italian Society of Veterinary Ophthalmology (SOVI, President 1989-98)
- Italian Society of Veterinary Neurology (SINVET, Vice-president 1989-92)
Present ongoing offices:
- ECVO Past-President
- Director CVIT Group Academy
- Editor of The Globe, ISVO Newsletters
- Consultant at Veterinary Ophthalmology Referrals in Torino, Milano, Samarate (Italy)
At present the main area of interest is Ocular Surface focusing on new diagnostic techniques and treatments.
1. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007 Apr; 5(2): 163-78.
2. Paugh JR, Nguyen AL, Ketelson HA, Christensen MT, Meadows DL. Precorneal residence time of artificial tears measured in dry eye subjects. Optom Vis Sci. 2008 Aug;85(8):725-31.
3. Garrett Q, Simmons PA, Xu S, et al. Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2007;48:1559-67.
4. Garrett Q, Xu S, Simmons PA, et al. Carboxymethyl cellulose stimulates rabbit corneal epithelial wound healing. Curr Eye Res. 2008 Jul;33(7):567-73.
5. Zheng LL, Myung D, Yu CQ, Ta CN. Comparative In vitro Cytotoxicity of Artificial Tears. JSM Ophthalmol 2015;3(1): 1026.
6. Diebold Y, Herreras JM, Callejo S, Argueso P, Calonge M. Carbomer- versus cellulose-based artificial-tear formulations: morphologic and toxicologic effects on a corneal cell line. Cornea. 1998 Jul;17(4):433-40.
7. Tong L, Petznick A, Lee S, Tan J. Choice of artificial tear formulation for patients withdry eye: where do we start? Cornea. 2012 Nov;31 Suppl
8. Berger JS, Head KR, Salmon TO. Comparison of two artificial tear formulations using aberrometry. Clin Exp Optom. 2009;92:206–211.
9. Ridder WH III, Lamotte JO, Ngo L, et al. Short-term effects of artificial tears on visual performance in normal subjects. Optom Vis Sci. 2005;82:370–377.
10. Baudouin C, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013 Oct;11(4):246-58.
11. Hirata H, et al. Hyperosmolar Tears Induce Functional and Structural Alterations of Corneal Nerves: Electrophysiological and Anatomical Evidence Toward Neurotoxicity. Invest Ophthalmol Vis Sci. 2015 Dec;56(13):8125-40.
12. Mager WH, Siderius M. Novel insights into the osmotic stress response of yeast. FEMS Yeast Res. 2002 Aug;2(3):251-7.
13. Lievens C, Berdy G, Douglass D et al. Clinical Evaluation of a New Enhanced Viscosity Eye Drop for Moderate to Severe Dry Eye Disease: A Multicenter, Double-Masked, Randomized 30-Day Study. AAOptAnnual Meeting, Oct 7–10, 2015, New Orleans, LA, USA.
14. Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010 Jan;128(1):94-101.
15. Roth H-W, Conway T, Hollander DA. Evaluation of carboxymethylcellulose 0.5%/ glycerin 0.9% and sodium hyaluronate 0.18% artificial tears in patients with mild to moderate dry eye. Clin Optom. 2011:3;73–78.
16. Deng R, et al. Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells. Mol Vis. 2014 Sep 12;20:1243-52.
17. Hua X, et al. Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human
corneal epithelial cells exposed to hyperosmotic stress. Curr Eye Res. 2015 Jul;40(7):657-67.
18. Hua X,et al. Protective Effects of L-Carnitine Against Oxidative Injury by Hyperosmolarity in Human Corneal Epithelial Cells. Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5503-11. 19. P. A. Simmons, J.-E. Chang- Lin, Q. Chung, J. G. Vehige, D. Welty; Effect of Compatible Solutes on Transepithelial Electrical Resistance and Uptake in Primary Rabbit Corneal Epithelial Cell Layers Model. Invest. Ophthalmol. Vis. Sci. 2007;48(13):428.